FluoGuide

34.85

SEK

-0.57 %

FLUO

First North Stockholm

Medical Equipment & Services

Health Care

7 following

-0.57%

-11.21%

-13.52%

-28.73%

-43.06%

-53.28%

-60.67%

+355.46%

+288.72%

fluoguide.com/investor/share-information

FluoGuide is a Danish company active in medical technology. The company's business focus is found in research and development of treatments against various forms of cancer, with the greatest focus on the development of products that guide surgical interventions. The products bind to the cancer cells, which then light up and are intended to be used to precisely remove harmful tumors in the patient's tissue.

Revenue

-

EBIT %

-

P/E

-

Dividend yield-%

-

Target price

-

Recommendation

-

Updated

-

First North Stockholm

FLUO

Daily low / high price

34.15 / 35.2 SEK

Market cap

474.66M SEK

Turnover

205.7K SEK

Volume

6K

Latest videos

FluoGuide – partnerskaber og udvikling i hoved-hals kræft

Introduktion til FluoGuide

Introduction to FluoGuide

Financial calendar

Interim report

27.11.2024

Annual report

27.02.2025

Major Owners
Source: Millistream Market Data AB

Owner	Capital	Votes
Life Science IVS	17.4 %	17.4 %
Wexotec ApS	12.2 %	12.2 %
ARBEJDERNES LANDSBANK A/S	7.2 %	7.2 %
LINC AB	7.1 %	7.1 %

Login in to make your own estimates and see other investors estimates.

ShowingAll content types

Press release2 days ago

Publication of positive phase II clinical data for FG001 in patients with head and neck cancer

Regulatory press release11/12/2024, 5:23 PM

FluoGuide A/S issue warrants to board member, CMO and CFO

Press release10/21/2024, 2:13 PM

Roger Gunnarsson resigns as board member due to return to a full-time investment banking career, which precludes him from holding board position in FluoGuide

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Press release10/7/2024, 11:13 AM

FluoGuide A/S submits Clinical Trial Application for phase II trial in head and neck cancer

Press release8/29/2024, 5:19 PM

Redeye: Fluoguide Q2 2024 - Following the plan

Regulatory press release8/29/2024, 6:55 AM

FluoGuide A/S publishes interim report for the period January – June 2024

Regulatory press release8/26/2024, 7:05 AM

FluoGuide appoints Jens Ellrich as Chief Medical Officer

Regulatory press release6/18/2024, 9:12 PM

FluoGuide has completed a directed share issue to existing and new investors raising proceeds of SEK 60 million

Regulatory press release6/18/2024, 3:31 PM

FluoGuide intends to carry out a directed share issue of approximately SEK 60 million

Press release5/30/2024, 2:51 PM

Redeye: Fluoguide Q1 2024 - Preparing for next steps

Regulatory press release5/30/2024, 6:51 AM

FluoGuide A/S publishes interim report for the period January – March 2024

Press release5/27/2024, 7:40 AM

FluoGuide selects laser system for photothermal cancer therapy with FG001

Dagens aktienyheder 21/03: Green Hydrogen Systems, Hafnia, TORM, MapsPeople og FluoGuide A/S

Analyst Comment3/21/2024, 8:05 AM

Dagens aktienyheder 21/03: Green Hydrogen Systems, Hafnia, TORM, MapsPeople og FluoGuide A/S

Dagens aktienyheder med Green Hydrogen Systems, Hafnia, TORM, MapsPeople og FluoGuide A/S

Green Hydrogen Systems Hafnia Torm MapsPeople FluoGuide

Fluoguide: Wrap up from interview with CEO Morten Albrechtsen

Analyst Comment3/21/2024, 7:30 AM by

Fluoguide: Wrap up from interview with CEO Morten Albrechtsen

Dive into the company's latest partnership with Intuitive Surgical and how the partnership looks like for Fluoguide.

Regulatory press release3/20/2024, 1:25 PM

Minutes from Annual General Meeting in FluoGuide A/S

FluoGuide – partnerskaber og udvikling i hoved-hals kræft

Webcast3/19/2024, 3:00 PM

FluoGuide – partnerskaber og udvikling i hoved-hals kræft

Deltag i vores virtuelle event den 19. marts kl. 16:00 for en gennemgang af FluoGuide’s nyligt offentliggjorte samarbejde med en af verdens førende robotkirurgi selskaber, Intuitive Surgical, på hoved- og halskræft, samt det videre strategiske fokus indenfor hoved-halskræft.

Dagens aktienyheder 19/03: Boozt, MapsPeople og FluoGuide A/S

Analyst Comment3/19/2024, 8:05 AM

Dagens aktienyheder 19/03: Boozt, MapsPeople og FluoGuide A/S

Dagens aktienyheder med Boozt, MapsPeople og FluoGuide A/S

Boozt MapsPeople FluoGuide

HCA Biosnack update: Biotech and Life Science stocks outperform as the general stock market moves to record highs.

Analyst Comment3/14/2024, 8:36 AM by

Henrik Ekman, Philip Coombes, Claus Thestrup

HCA Biosnack update: Biotech and Life Science stocks outperform as the general stock market moves to record highs.

After a slow start to 2024, February and the beginning of March turned out to be a very strong period for Biotech and Life Science stocks as illustrated above. Even more so, if measured since late October 2023. Looking at 2024, the general S&P Biotech index is now up 7.7 percent year-to-date, outperforming MSCI World All Countries which is up 7.0 percent. Nordic focused HCA Little Mermaid index is up 6.0 percent.

Ascelia Pharma BioPorto Curasight ExpreS2ion Biotech Holding FluoGuide NeoDynamics Pharma Equity Group Qlife Holding

Regulatory press release3/13/2024, 10:17 AM

Chief Financial Officer (CFO) Ole Larsen buys shares

Dagens aktienyheder 13/03: GreenMobility og FluoGuide

Analyst Comment3/13/2024, 8:07 AM by

Kasper Lihn, Michael Friis, Claus Thestrup

Dagens aktienyheder 13/03: GreenMobility og FluoGuide

Dagens aktienyheder med GreenMobility og FluoGuide

GreenMobility FluoGuide